US FDA approval for a human papillomavirus test for primary cervical cancer screening

被引：0
|
作者：
Bond, Theo
机构：
来源：
BIOMARKERS IN MEDICINE | 2014年 / 8卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：615 / 615
页数：1
相关论文
共 50 条
  • [31] Primary human papillomavirus testing in organized cervical screening
    Dillner, Joakim
    CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2013, 25 (01) : 11 - 16
  • [32] Primary Human Papillomavirus Screening: Women's Perceptions of New Cervical Cancer Screening Recommendations
    Cannizzaro, Nancy T.
    Mittman, Brian S.
    Hahn, Erin E.
    Ngo-Metzger, Quyen
    Gould, Michael K.
    Hsu, Chunyi
    Shen, Ernest
    Tewari, Devansu
    Chao, Chun R.
    JOURNAL OF WOMENS HEALTH, 2024, 33 (12) : 1614 - 1624
  • [33] Are Health Care Professionals Prepared to Implement Human Papillomavirus Testing? A Review of Psychosocial Determinants of Human Papillomavirus Test Acceptability in Primary Cervical Cancer Screening
    Tatar, Ovidiu
    Wade, Kristina
    McBride, Emily
    Thompson, Erika
    Head, Katharine J.
    Perez, Samara
    Shapiro, Gilla K.
    Waller, Jo
    Zimet, Gregory
    Rosberger, Zeev
    JOURNAL OF WOMENS HEALTH, 2020, 29 (03) : 390 - 405
  • [34] US physicians' intentions regarding impact of human papillomavirus vaccine on cervical cancer screening
    Wong, Charlene
    Berkowitz, Zahava
    Saraiya, Mona
    Wideroff, Louise
    Benard, Vicki B.
    SEXUAL HEALTH, 2010, 7 (03) : 338 - 345
  • [35] Factors associated with human papillomavirus (HPV) test acceptability in primary screening for cervical cancer: A mixed methods research synthesis
    Tatar, Ovidiu
    Thompson, Erika
    Naz, Anila
    Perez, Samara
    Shapiro, Gilla K.
    Wade, Kristina
    Zimet, Gregory
    Gilca, Vladimir
    Janda, Monika
    Kahn, Jessica
    Daley, Ellen
    Rosberger, Zeev
    PREVENTIVE MEDICINE, 2018, 116 : 40 - 50
  • [36] Should human papillomavirus DNA testing be offered in combination with cytology or as a sole primary screening test in cervical cancer prevention?
    Tristram, Amanda
    FUTURE ONCOLOGY, 2012, 8 (07) : 783 - 786
  • [37] Age patterns of human papillomavirus infection as primary screening test for cervical cancer and subsequent triage with visual inspection in Honduras
    Sandoval, Manuel
    Holme, Francesca
    Lobo, Saul
    Slavkovsky, Rose
    Thomson, Kerry A.
    Jeronimo, Jose
    Figueroa, Jacqueline
    de Sanjose, Silvia
    SALUD PUBLICA DE MEXICO, 2020, 62 (05): : 487 - 493
  • [38] Approaches for triaging women who test positive for human papillomavirus in cervical cancer screening
    Tota, Joseph E.
    Bentley, James
    Blake, Jennifer
    Coutlee, Francois
    Duggan, Maire A.
    Ferenczy, Alex
    Franco, Eduardo L.
    Fung-Kee-Fung, Michael
    Gotlieb, Walter
    Mayrand, Marie-Helene
    McLachlin, Meg
    Murphy, Joan
    Ogilvie, Gina
    Ratnam, Sam
    PREVENTIVE MEDICINE, 2017, 98 : 15 - 20
  • [39] High-risk human papillomavirus test a good option for cervical cancer screening
    Printz, Carrie
    CANCER, 2018, 124 (24) : 4591 - 4591
  • [40] Cytology and High-Risk Human Papillomavirus Test for Cervical Cancer Screening Assessment
    Stuebs, Frederik A.
    Koch, Martin C.
    Dietl, Anna K.
    Adler, Werner
    Geppert, Carol
    Hartmann, Arndt
    Knoell, Antje
    Beckmann, Matthias W.
    Mehlhorn, Grit
    Schulmeyer, Carla E.
    Gass, Paul
    DIAGNOSTICS, 2022, 12 (07)
12345